The Time Is Right To Purchase Planet Labs PBC (NYSE: PL)

During the last session, Planet Labs PBC (NYSE:PL)’s traded shares were 4.4 million, with the beta value of the company hitting 1.41. At the end of the trading day, the stock’s price was $6.11, reflecting an intraday loss of -1.29% or -$0.08. The 52-week high for the PL share is $6.71, that puts it down -9.82 from that peak though still a striking 72.67% gain since the share price plummeted to a 52-week low of $1.67. The company’s market capitalization is $1.83B, and the average intraday trading volume over the past 10 days was 9.75 million shares, and the average trade volume was 6.28 million shares over the past three months.

Planet Labs PBC (PL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.18. PL has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.02.

Planet Labs PBC (NYSE:PL) trade information

Planet Labs PBC (PL) registered a -1.29% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.29% in intraday trading to $6.11, hitting a weekly high. The stock’s 5-day price performance is -4.08%, and it has moved by 71.15% in 30 days. Based on these gigs, the overall price performance for the year is 163.36%. The short interest in Planet Labs PBC (NYSE:PL) is 5.29 million shares and it means that shorts have 1.67 day(s) to cover.

The consensus price target of analysts on Wall Street is $5.65, which implies a decrease of -8.14% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $6.3 respectively. As a result, PL is trading at a discount of -3.11% off the target high and 18.17% off the low.

Planet Labs PBC (PL) estimates and forecasts

In the rating firms’ projections, revenue will increase 10.88% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 61.88M as predicted by 11 analyst(s). Meanwhile, a consensus of 10 analyst(s) estimates revenue growth to 64.56M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 58.85M and 60.44M respectively. In this case, analysts expect current quarter sales to grow by 5.15% and then jump by 6.81% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 35.30%. While earnings are projected to return 37.08% in 2025, the next five years will return 45.94% per annum.

PL Dividends

Planet Labs PBC is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 14.71 million shares, is of VANGUARD GROUP INC’s that is approximately 5.1027% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $27.36 million.

Also, the Mutual Funds coming in first place with the largest holdings of Planet Labs PBC (PL) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 6.39 shares. This amounts to just over 2.30 percent of the company’s overall shares, with a $39.04 million market value. The same data shows that the other fund manager holds slightly less at 5.93, or about 2.13% of the stock, which is worth about $36.24 million.